Alpha Tau Medical (DRTSW) Other Non-Current Assets (2020 - 2026)
Alpha Tau Medical (DRTSW) posted Other Non-Current Assets of $462000.0 for Q1 2026, down 3.55% sequentially from $479000.0 in Q4 2025, and up 5.24% YoY from $439000.0 in Q1 2025.
Alpha Tau Medical (DRTSW) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Other Non-Current Assets for 7 years, with the latest figure at $462000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 5.24% year-over-year to $462000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $462000.0 (up 5.24% YoY) and the FY2025 annual result came in at $479000.0, up 10.88% from the prior year.
- Other Non-Current Assets eased to $462000.0 in Q1 2026 per DRTSW's latest filing, from $479000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $223.0 million in Q1 2022 and troughed at $391000.0 in Q4 2022.
- A 5-year average of $13.6 million and a median of $441000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 20.46% in 2023, down 99.8% in 2023.
- Over 5 years, Other Non-Current Assets stood at $391000.0 in 2022, then gained by 20.46% to $471000.0 in 2023, then decreased by 8.28% to $432000.0 in 2024, then increased by 10.88% to $479000.0 in 2025, then slipped by 3.55% to $462000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $462000.0, $479000.0, and $472000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 65.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 104.44 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 62.96 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 202.31 Mn |
| 10 | Alpha Tau Medical | 347.77 Mn | 165.35 Mn | - | 525,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 525,000.00 |
| Mar 31, 2026 | 462,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 463,000.00 |
| Mar 31, 2025 | 439,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Sep 30, 2024 | 438,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Mar 31, 2024 | 465,000.00 |
| Dec 31, 2023 | 471,000.00 |
| Sep 30, 2023 | 441,000.00 |
| Jun 30, 2023 | 441,000.00 |
| Mar 31, 2023 | 441,000.00 |
| Dec 31, 2022 | 391,000.00 |
| Sep 30, 2022 | 393,000.00 |
| Jun 30, 2022 | 792,000.00 |
| Mar 31, 2022 | 223.00 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | 139,000.00 |